Determining the various costs of Medicare can be confusing. There are annual deductibles, monthly premiums and doctor visit ...

In a report released today, Bob Huang from Morgan Stanley maintained a Buy rating on Metlife (MET – Research Report), with a price target of ...

UnitedHealthcare offers a variety of Medicare Advantage plans with a wide range of benefits, often with $0 premiums, copays ...

Keefe Bruyette lowered the firm’s price target on MetLife (MET) to $98 from $100 and keeps an Outperform rating on the shares.Maximize Your ...

MetLife, Inc. is rated a buy due to its solid value, above-market dividend yield, and favorable technical chart despite ...